August 2020: Avraham nominated to the advisory board of CureGRIN

Prof. Karen Avraham, Edmond J. Safra member (Medicine) was nominated to the Science & Medical Advisory board of CureGRIN.

GRIN disorder is a rare genetic condition with severe life-limiting consequences. CureGRIN's goal is to find cures and therapies for people around the world suffering from single-gene disorders. It is committed to ensuring collaboration between clinicians, researchers, biotech companies and patient advocates, sharing everything from theories and results, to animal models and technologies.